BEAM icon

Beam Therapeutics

Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$52
70% upside
High target

4 analyst ratings

positive
neutral
25%
negative
Analyst & Firm Rating Price Target Upside
Downside
Date
RBC Capital
RBC Capital
Luca Issi
25 Feb ‘26 1 month ago
Wedbush
Wedbush
David Nierengarten
0% 1-yr BEAM win rate
25 Feb ‘26 1 month ago
Canaccord Genuity
Canaccord Genuity
Whitney Ijem
0% 1-yr BEAM win rate
20 Feb ‘26 1 month ago
Bernstein
Bernstein
William Pickering
0% 1-yr BEAM win rate
21 Jan ‘26 2 months ago